Sign In
Buy DRIO
$7.50
-0.1000 (-1.32%)
At Close: Jun 05, 2026
DarioHealth Enters Into a Partnership With Vitality to Accelerate Penetration Into the Self-insured Employer Market
12:30pm, Tuesday, 24'th Mar 2020
DarioHealth Corp. (Nasdaq: DRIO) ("Dario") a pioneer in the global digital therapeutics market, announced today that it has entered into a partnership with Vitality Group, a global health and wellness
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs March 19.) * Biomerica, Inc. (NASDAQ: BMRA) * Centogene NV (
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs March 19.)
Biomerica, Inc. (NASDAQ...
DarioHealth Reports Fourth Quarter and Year End 2019 Results
10:30am, Tuesday, 17'th Mar 2020
DarioHealth Corp. (Nasdaq: DRIO), a global digital therapeutics (DTx) innovator, today reported financial results for the fourth quarter and full year ended December 31, 2019 and provided a corporate
The Week Ahead In Biotech: COVID-19 Updates, Tapering Earnings Flow, Eton's Seizure Drug Review
01:55pm, Sunday, 15'th Mar 2020
The biopharma space bled along with the rest of the market and COVID-19 levered biotechs weren't spared either.Biogen Inc (NASDAQ: BIIB) was in the news for all wrong reasons, as an employee conferenc
The Week Ahead In Biotech: COVID-19 Updates, Tapering Earnings Flow, Eton's Seizure Drug Review
12:00am, Sunday, 15'th Mar 2020
The biopharma space bled along with the rest of the market and COVID-19 levered biotechs weren't spared either.
Biogen Inc (NASDAQ: BIIB) was in the news for all wrong...
DarioHealth to Host Fourth Quarter 2019 Conference Call March 17, 2020
12:30pm, Thursday, 12'th Mar 2020
Global digital therapeutics innovation leader DarioHealth Corp. (NASDAQ: DRIO) today announced it will release its fourth quarter and year end 2019 results on Tuesday, March 17, and host a conference
DarioHealth Appoints Two New Board Members
01:30pm, Thursday, 05'th Mar 2020
DarioHealth Corp. (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, announced today the company has appointed Yadin Shemmer and Adam K. Stern to serve as board members effective imm
Those Who Purchased DarioHealth (NASDAQ:DRIO) Shares Five Years Ago Have A 90% Loss To Show For It
01:04pm, Wednesday, 04'th Mar 2020
Long term investing is the way to go, but that doesn't mean you should hold every stock forever. We don't wish...
DarioHealth Digital Diabetes Management System is Now Available at Albertsons
01:00pm, Monday, 24'th Feb 2020
DarioHealth Corp. (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, announced today the launch of its digital therapeutics solution for managing chronic diseases such as diabetes an
DarioHealth Corp. (Nasdaq: DRIO) ("DarioHealth" or "Dario"), a pioneer in the global digital therapeutics market, today presented a new clinical study at the Advanced Technologies & Treatments for Dia
DarioHealth Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
10:30pm, Friday, 31'st Jan 2020
DarioHealth Corp. (Nasdaq: DRIO) ("DarioHealth" or the "Company"), a pioneer in the global digital therapeutics market, announced today that on January 30, 2020, Richard Anderson was granted a non-qua
Israeli digital therapeutics company raises $21.3M for U.S. expansion
09:32pm, Friday, 20'th Dec 2019
Publicly-traded DarioHealth plans to use the cash to put its smartphone-based glucometer into the hands of insurers.
